Stock Earnings

Question 1

What are Amplia Therapeutics Ltd's key financial statements?

Accepted Answer

According to the latest financial statement (Form-10K), Amplia Therapeutics Ltd has a total asset of $22, Net loss of $-6

Question 2

What are the key financial ratios for INNMF?

Accepted Answer

Amplia Therapeutics Ltd's Current ratio is 22, has a Net margin is -200, sales per share of $0.

Question 3

How is Amplia Therapeutics Ltd's revenue broken down by segment or geography?

Accepted Answer

Amplia Therapeutics Ltd largest revenue segment is Focal Adhesion Kinase, at a revenue of 15,000 in the most earnings release.For geography, Australia is the primary market for Amplia Therapeutics Ltd, at a revenue of 15,000.

Question 4

Is Amplia Therapeutics Ltd profitable?

Accepted Answer

no, according to the latest financial statements, Amplia Therapeutics Ltd has a net loss of $-6

Question 5

Does Amplia Therapeutics Ltd have any liabilities?

Accepted Answer

yes, Amplia Therapeutics Ltd has liability of 1

Question 6

How many outstanding shares for Amplia Therapeutics Ltd?

Accepted Answer

Amplia Therapeutics Ltd has a total outstanding shares of 387.95

Breakdown	TTM	03/31/2025	03/31/2024	03/31/2023	03/31/2022	03/31/2021
Revenue	5	3	4	1	1	1
Revenue Growth (YoY)	67%	-25%	300%	0%	0%	--
Cost of Revenue	--	--	--	--	--	--
Gross Profit	--	--	--	--	--	--
Selling, General & Admin	3	2	3	2	1	1
Research & Development	9	7	5	4	3	2
Operating Expenses	13	10	9	7	5	3
Other Non Operating Income (Expenses)	--	0	0	0	--	--
Pretax Income	-7	-6	-4	-6	-3	-2
Income Tax Expense	0	0	--	0	0	0
Net Income	-7	-6	-4	-6	-3	-2
Net Income Growth	17%	50%	-33%	100%	50%	0%
Shares Outstanding (Diluted)	426.45	307.2	203.66	203.63	152.79	98.46
Shares Change (YoY)	65%	51%	0%	33%	55%	86%
EPS (Diluted)	-0.02	-0.02	-0.02	-0.03	-0.02	-0.02
EPS Growth	-26%	-3%	-28%	28%	3%	-45%
Free Cash Flow	-13	-6	-5	-5	-4	-2
Free Cash Flow Per Share	-0.03	-0.01	-0.02	-0.02	-0.02	-0.02
Gross Margin	--	--	--	--	--	--
Operating Margin	-160%	-200%	-100%	-600%	-300%	-200%
Profit Margin	-140%	-200%	-100%	-600%	-300%	-200%
Free Cash Flow Margin	-260%	-200%	-125%	-500%	-400%	-200%
EBITDA	-8	-6	-4	-6	-3	-2
EBITDA Margin	-160%	-200%	-100%	-600%	-300%	-200%
D&A For EBITDA	0	0	0	0	0	0
EBIT	-8	-6	-4	-6	-3	-2
EBIT Margin	-160%	-200%	-100%	-600%	-300%	-200%
Effective Tax Rate	0%	0%	--	0%	0%	0%

Amplia Therapeutics Ltd (INNMF) Price

INNMF Stock Price Chart

INNMF Income

Follow-Up Questions